A promising treatment for Immune Thrombocytopenia (ITP), an autoimmune disease in which the immune system targets platelets, resulting in reduced platelet counts and an elevated risk of bleeding, is umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy. Although they frequently have adverse effects and don’t always result in long-term remission, conventional treatments including steroids, immunosuppressants, and […]
Search Diseases & Conditions....

